Trials / Unknown
UnknownNCT04900584
Optimize Heart Failure Care During TRANSitional Period in Patients With Acute Heart Failure.
A Prospective Randomized Multicenter Controlled Study to Optimize Heart Failure Care During TRANSitional Period in Patients With Acute Heart Failure With Reduced Ejection Fraction.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,009 (actual)
- Sponsor
- Wonju Severance Christian Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The period of about a month after the discharge of acute heart failure patients is defined as a transition time. During this period, the patient has a high mortality rate and a readmission rate because the patient is not stabilized. In the United States and Europe, the readmission rate is more than 25% within 30 days, and the mortality rate within 30 days after discharge is three times that of patients with chronic heart failure. The TRANS-HF is a prospective, randomized, multi-center, controlled study, which enrolls patients with acute heart failure with reduced ejection fraction. The objective of TRANS-HF is to improve GAI at six months through three interventions: pre-discharge checklist, heart failure education, and telephone monitoring before the first outpatient visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Checklist | Checklist of guideline-based treatment before discharge |
| OTHER | Education | Heart failure education before discharge |
| OTHER | Telephone monitoring | Telephone monitoring after discharge |
Timeline
- Start date
- 2020-06-23
- Primary completion
- 2022-10-31
- Completion
- 2023-02-28
- First posted
- 2021-05-25
- Last updated
- 2022-06-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04900584. Inclusion in this directory is not an endorsement.